186 related articles for article (PubMed ID: 25115512)
1. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.
Boi M; Zucca E; Inghirami G; Bertoni F
Leuk Lymphoma; 2015 May; 56(5):1223-8. PubMed ID: 25115512
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.
Pasqualucci L; Compagno M; Houldsworth J; Monti S; Grunn A; Nandula SV; Aster JC; Murty VV; Shipp MA; Dalla-Favera R
J Exp Med; 2006 Feb; 203(2):311-7. PubMed ID: 16492805
[TBL] [Abstract][Full Text] [Related]
3. PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL.
Cubedo E; Maurin M; Jiang X; Lossos IS; Wright KL
FEBS J; 2011 Sep; 278(17):3065-75. PubMed ID: 21722313
[TBL] [Abstract][Full Text] [Related]
4. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma.
Boi M; Rinaldi A; Kwee I; Bonetti P; Todaro M; Tabbò F; Piva R; Rancoita PM; Matolcsy A; Timar B; Tousseyn T; Rodríguez-Pinilla SM; Piris MA; Beà S; Campo E; Bhagat G; Swerdlow SH; Rosenwald A; Ponzoni M; Young KH; Piccaluga PP; Dummer R; Pileri S; Zucca E; Inghirami G; Bertoni F
Blood; 2013 Oct; 122(15):2683-93. PubMed ID: 24004669
[TBL] [Abstract][Full Text] [Related]
5. Blimp-1 is a tumor suppressor gene in lymphoid malignancies.
Hangaishi A; Kurokawa M
Int J Hematol; 2010 Jan; 91(1):46-53. PubMed ID: 20047096
[TBL] [Abstract][Full Text] [Related]
6. ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.
Valera A; Colomo L; Martínez A; de Jong D; Balagué O; Matheu G; Martínez M; Taddesse-Heath L; Jaffe ES; Bacchi CE; Campo E
Mod Pathol; 2013 Oct; 26(10):1329-37. PubMed ID: 23599149
[TBL] [Abstract][Full Text] [Related]
7. Novel BLIMP1/PRDM1 gene mutations in B-cell lymphoma.
Tate G; Hirayama-Ohashi Y; Kishimoto K; Mitsuya T
Cancer Genet Cytogenet; 2007 Jan; 172(2):151-3. PubMed ID: 17213024
[TBL] [Abstract][Full Text] [Related]
8. Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
Courts C; Montesinos-Rongen M; Brunn A; Bug S; Siemer D; Hans V; Blümcke I; Klapper W; Schaller C; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2008 Jul; 67(7):720-7. PubMed ID: 18596541
[TBL] [Abstract][Full Text] [Related]
9. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
10. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.
Cattoretti G; Angelin-Duclos C; Shaknovich R; Zhou H; Wang D; Alobeid B
J Pathol; 2005 May; 206(1):76-86. PubMed ID: 15772984
[TBL] [Abstract][Full Text] [Related]
11. Conserved and Unique Functions of Blimp1 in Immune Cells.
Nadeau S; Martins GA
Front Immunol; 2021; 12():805260. PubMed ID: 35154079
[TBL] [Abstract][Full Text] [Related]
12. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
13. GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.
Baron BW; Anastasi J; Bies J; Reddy PL; Joseph L; Thirman MJ; Wroblewski K; Wolff L; Baron JM
Blood Cells Mol Dis; 2014 Jan; 52(1):68-75. PubMed ID: 23910958
[TBL] [Abstract][Full Text] [Related]
14. Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas.
Afshar-Sterle S; Zotos D; Bernard NJ; Scherger AK; Rödling L; Alsop AE; Walker J; Masson F; Belz GT; Corcoran LM; O'Reilly LA; Strasser A; Smyth MJ; Johnstone R; Tarlinton DM; Nutt SL; Kallies A
Nat Med; 2014 Mar; 20(3):283-90. PubMed ID: 24487434
[TBL] [Abstract][Full Text] [Related]
15. BLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomas.
Vrzalikova K; Woodman CB; Murray PG
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):1-6. PubMed ID: 22580854
[TBL] [Abstract][Full Text] [Related]
16. Blimp1 is limiting for transformation in a mouse plasmacytoma model.
D'Costa K; Emslie D; Metcalf D; Smyth GK; Karnowski A; Kallies A; Nutt SL; Corcoran LM
Blood; 2009 Jun; 113(23):5911-9. PubMed ID: 19329782
[TBL] [Abstract][Full Text] [Related]
17. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
18. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.
Jaye DL; Iqbal J; Fujita N; Geigerman CM; Li S; Karanam S; Fu K; Weisenburger DD; Chan WC; Moreno CS; Wade PA
J Pathol; 2007 Sep; 213(1):106-15. PubMed ID: 17573669
[TBL] [Abstract][Full Text] [Related]
19. The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10.
Mock BA; Liu L; LePaslier D; Huang S
Genomics; 1996 Oct; 37(1):24-8. PubMed ID: 8921366
[TBL] [Abstract][Full Text] [Related]
20. A role for Blimp1 in the transcriptional network controlling natural killer cell maturation.
Kallies A; Carotta S; Huntington ND; Bernard NJ; Tarlinton DM; Smyth MJ; Nutt SL
Blood; 2011 Feb; 117(6):1869-79. PubMed ID: 21131593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
